Beta-blockers and the treatment of hypertension : it is time to move on
| dc.contributor.author | Wiysonge, Charles Shey | |
| dc.contributor.author | Volmink, Jimmy | |
| dc.contributor.author | Opie, Lionel H. | |
| dc.date.accessioned | 2012-01-24T09:14:32Z | |
| dc.date.available | 2012-01-24T09:14:32Z | |
| dc.date.issued | 2007-12 | |
| dc.description | The original publication is available at http://www.cvja.co.za/ | en_ZA |
| dc.description.abstract | Existing solid scientific evidence with hard outcome data should be the basis for treatment guidelines, and where such evidence is lacking, we must invest in research. A case in point is the initiation of antihypertensive treatment with a beta-blocker. Beta-blockers are pharmacological agents that block the action of endogenous catecholamines on beta-adrenergic receptors, part of the sympathetic nervous system which mediates the ‘fight or flight’ response. | en_ZA |
| dc.description.version | Publisher's version | en_ZA |
| dc.format.extent | p. 351-352 | |
| dc.identifier.citation | Wiysonge, C. S., Volmink, J. & Opie, L. H. 2007. Beta-blockers and the treatment of hypertension: it is time to move on. Cardiovasular Journal of Africa, 18(6), 351 - 352. | en_ZA |
| dc.identifier.issn | 1680-0745 (online) | |
| dc.identifier.issn | 1995-1892 (print) | |
| dc.identifier.uri | http://hdl.handle.net/10019.1/19362 | |
| dc.language.iso | en_ZA | en_ZA |
| dc.publisher | Clinics Cardiv Publishing | en_ZA |
| dc.rights.holder | Cardiovascular Journal of Africa | en_ZA |
| dc.subject | Beta-blockers | en_ZA |
| dc.subject | Hypertension -- Treatment | en_ZA |
| dc.title | Beta-blockers and the treatment of hypertension : it is time to move on | en_ZA |
| dc.type | Article | en_ZA |